Latest Insider Positions

COX HOWARD E JR is listed as an insider in the following companies: SYK / Stryker Corp. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.


Security Title Post Shares
SYK / Stryker Director 525,452

Latest Transactions

Tran Date
Security Code Shares Post Shares Percent
2018-03-21 SYK / Stryker M 720 525,452 0.14
2018-02-02 SYK / Stryker S -7,400 524,732 -1.39 164.0893 -1,214,261 86,102,907 -1.41
2018-01-08 SYK / Stryker M 7,400 532,132 1.41 67.80 501,720
2017-12-06 SYK / Stryker G -30,000 524,732 -5.41
2017-04-28 SYK / Stryker S -8,615 554,732 -1.53 136.11 -1,172,588 75,504,573 -1.55
2017-03-21 SYK / Stryker M 915 563,347 0.16
2017-01-06 SYK / Stryker M 7,700 562,432 1.39 62.65 482,405
2016-08-01 SYK / Stryker S -9,448 554,732 -1.67 117.02 -1,105,605 64,914,739 -1.70
2016-03-21 SYK / Stryker M 948 564,180 0.17
2016-01-07 SYK / Stryker M 8,500 563,232 1.53 46.85 398,225
2015-11-16 SYK / Stryker G -30,000 554,732 -5.13
2015-07-31 SYK / Stryker S -10,469 584,732 -1.76 102.1545 -1,069,455 59,733,005 -1.79
2015-03-21 SYK / Stryker M 1,089 595,201 0.18
2015-03-05 SYK / Stryker S -11,225 594,112 -1.85 92.8214 -1,041,920 55,146,308 -1.89
Open market or private purchase of non-derivative or derivative security
Open market or private sale of non-derivative or derivative security
Grant, award, or other acquisition of securities from the company (such as an option)
Conversion of derivative
Sale or transfer of securities back to the company
Payment of exercise price or tax liability using portion of securities received from the company
Gift of securities by or to the insider
Equity swaps and similar hedging transactions
Exercise or conversion of derivative security received from the company (such as an option)
A transaction voluntarily reported on Form 4
Other (accompanied by a footnote describing the transaction)

Peers of COX HOWARD E JR include the following: BRAINERD MARY K, Becker Yin C, Benscoter Steven P, Berry William E Jr, Boehnlein Glenn S, Carpenter Lonny J, Datar Srikant, Doliveux Roch, FRANCESCONI LOUISE, Fink M Kathryn, Floyd David, Golston Allan C., Hutchinson Michael David, Lobo Kevin, McCoy Sherilyn S, McLean Graham A, Menon Viju, Owen Katherine Ann, PARFET WILLIAM U, STRYKER RONDA E, Sagar Bijoy, Scannell Timothy J, Silvernail Andrew K, Subrahmanian Ramesh, Suri Rajeev, . Peers are determined by cross-linking the filings of COX HOWARD E JR with insider filings of others at the same companies.

Related News Stories

What's in Store for AngioDynamics (ANGO) in Q1 Earnings?

12h zacks
AngioDynamics Inc. (ANGO - Free Report) is set to report first-quarter fiscal 2019 results on Sep 27, before market open. (3-0)

On Stryker's Value

2018-09-13 seekingalpha
Stryker has a robust dividend due to the recurring nature of many of its MedSurg products and its strong sales capabilities. (2-0)

3 Stocks to Watch as Bots Take Bigger Strides in US Healthcare

2018-09-13 zacks
With massive advances in the fields of robots and artificial intelligence, the gap between fiction and reality has disappeared. (3-0)

Stock Market News For Sep 12, 2018

2018-09-12 zacks
Markets ended sharply higher on Tuesday, led by a rally in tech and energy stocks, as trade war fears continued to linger. The tech rally was led by Apple, while a gain of more than 2% in oil helped energy stocks. This saw all three major indexes ending in positive territory, with Dow climbing by triple digits. (48-0)

Stryker (SYK) to Acquire Invuity, Boost Surgical Portfolio

2018-09-12 zacks
Stryker Corporation (SYK - Free Report) recently announced an agreement to acquire Invuity Inc. for approximately $190 million. This buyout is expected to augment Stryker’s surgical portfolio, thereby aiding the core Neurotechnology & Spine segment. The deal is expected to close in the fourth quarter of 2018. (4-0)